Naringenin attenuates cisplatin nephrotoxicity in rats

Life Sci. 2005 Mar 18;76(18):2125-35. doi: 10.1016/j.lfs.2004.11.005. Epub 2005 Jan 22.

Abstract

The effect of naringenin (NAR), a naturally occurring citrus flavanone, on the acute nephrotoxicity produced by cisplatin (7 mg/kg, i.v.) was investigated in the rat. Oral administration of NAR (20 mg/kg/day) for 10 days, starting 5 days before cisplatin single i.v. injection, produced significant protection of renal function. NAR reduced the extent of cisplatin-induced nephrotoxicity, as evidenced by significant reduction in serum urea and creatinine concentrations, decreased polyuria, reduction in body weight loss, marked reduction in urinary fractional sodium excretion and glutathione S-transferase (GST) activity, and increased creatinine clearance. Cisplatin-induced alterations in renal cortex lipid peroxides and GST activity were markedly improved by NAR. Cisplatin-induced alterations in renal cortex antioxidant defense system were greatly prevented by NAR. In cisplatin-NAR combined treatment group, antioxidant enzymes namely superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), and catalase (CAT) were significantly increased to 54.5, 30.3 and 35.6%, respectively compared to cisplatin treated group. Platinum renal content was not affected by NAR treatment. The results provide further insight into the mechanisms of cisplatin-induced nephrotoxicity and confirm the antioxidant potential of NAR.

MeSH terms

  • Animals
  • Antineoplastic Agents / antagonists & inhibitors
  • Antineoplastic Agents / toxicity*
  • Cisplatin / antagonists & inhibitors
  • Cisplatin / toxicity*
  • Flavanones / pharmacology*
  • Kidney / chemistry
  • Kidney / enzymology
  • Kidney Diseases / chemically induced*
  • Kidney Diseases / pathology
  • Kidney Function Tests
  • Male
  • Platinum / analysis
  • Rats
  • Urea / blood

Substances

  • Antineoplastic Agents
  • Flavanones
  • Platinum
  • Urea
  • naringenin
  • Cisplatin